AzurRx BioPharma, Inc.
AZRXNASDAQHealthcare
$3.45
+$0.07(+2.07%)
Market Cap$3432760
P/E Ratio—
52W High$3.66
52W Low$3.38
AzurRx BioPharma, Inc.（AZRX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · AZRX · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.04M | $0.00M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 0.00% | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.93M | $0.90M | $5.89M | $8.68M | $4.99M |
| G&A Expenses | $5.50M | $14.72M | $7.29M | $6.06M | $8.24M |
| Total Operating Expenses | $6.43M | $15.62M | $26.43M | $14.74M | $13.43M |
| Operating Income | ($7.08M) | ($15.62M) | ($26.43M) | ($14.74M) | ($13.43M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | ($0.49M) | $0.00M | $5.84M | $0.43M | $0.10M |
| Income Before Tax | ($6.55M) | ($18.06M) | ($32.67M) | ($15.18M) | ($13.53M) |
| Income Tax Expense | $0.00M | $0.00M | ($0.40M) | $0.00M | $0.00M |
| Net Income | ($6.55M) | ($18.06M) | ($32.67M) | ($15.18M) | ($13.53M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-4.16 | $-5.33 | $-5.90 | $-6.77 | $-8.77 |
| Wtd Avg Shares | 1.62M | 3.43M | 5.53M | 2.24M | 1.54M |
| EBITDA | ($7.08M) | ($15.62M) | ($26.83M) | ($13.72M) | ($12.63M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解AzurRx BioPharma, Inc.
关于AzurRx BioPharma, Inc.（AZRX）损益表
AzurRx BioPharma, Inc.（AZRX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，AZRX实现营收$0.00B，毛利润$0.00B（毛利率0.00%），净利润($0.01B)（净利率-18078.34%）。
常见问题
AZRX · 4 问AzurRx BioPharma, Inc.（AZRX）2025财年营收为$0.00B，同比up—%。
AZRX revenueAZRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09